Market Cap (In EUR)
110.5 Million
Revenue (In EUR)
2.56 Million
Net Income (In EUR)
-20.75 Million
Avg. Volume
32.91 Thousand
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.052-3.5
- PE
- -
- EPS
- -
- Beta Value
- 0.801
- ISIN
- FI4000330972
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Prof. Edward Olof Haeggstrom
- Employee Count
- -
- Website
- https://www.nanoform.com
- Ipo Date
- 2020-06-04
- Details
- Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
More Stocks
-
CSR-PCCenterspace
CSR-PC
-
RIVX
-
1119
-
1522
-
600336AUCMA Co.,Ltd.
600336
-
INNMF
-
ACE
-
GPIL